Welcome to our dedicated page for OSH news (Ticker: OSH), a resource for investors and traders seeking the latest updates and insights on OSH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OSH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OSH's position in the market.
Oak Street Health (NYSE: OSH) will host a conference call on March 10, 2021, at 8:00 AM ET to discuss its fiscal Q4 2020 financial results, which will be released on March 9, 2021, after market close. Interested participants can join by dialing (833) 529-0224 for U.S. callers or +1 (236) 389-2153 for international callers, using participant code 6163985. A webcast replay will also be available post-call. Oak Street operates over 80 value-based primary care centers for Medicare adults across various states, prioritizing quality of care.
Oak Street Health (NYSE: OSH) expands its value-based primary care model to Atlanta, Georgia, this summer, marking its entry into the 14th state. The company is also set to open new centers in existing markets, including Brooklyn, NY, and South Philadelphia, PA, this spring. Additionally, Oak Street is entering Louisiana and South Carolina, with centers opening in New Orleans and Baton Rouge. The company highlights its success in reducing patient admissions and emergency visits while maintaining high patient satisfaction.
Oak Street Health, Inc. (NYSE: OSH) has announced the pricing for its public offering of 10,723,821 shares at $56.00 each, increasing the original offering from 9,000,000 shares. The underwriters have a 30-day option to purchase an additional 1,608,573 shares. The company will not receive any proceeds from the sale, as they are by selling stockholders, who will also cover associated costs. The offering is expected to close on February 16, 2021. J.P. Morgan, Goldman Sachs, and others are managing the offering.
Oak Street Health, Inc. (NYSE: OSH) has initiated an underwritten public offering of 9,000,000 shares of its common stock by certain selling stockholders, with a potential additional 1,350,000 shares subject to underwriters' option. Oak Street will not benefit from proceeds, as the selling stockholders will cover associated costs. Leading banks include J.P. Morgan and Goldman Sachs. A registration statement for these securities has been filed with the SEC but is not yet effective. Forward-looking statements caution that actual results may differ due to various risks.
Oak Street Health (NYSE: OSH) is collaborating with the City of Chicago and Cook County to enhance COVID-19 vaccination distribution for healthcare workers. In honor of Martin Luther King Jr. Day, six clinics have been designated as vaccination centers, aiming to serve minority communities. The organization has vaccinated over 2,300 healthcare workers, including 1,000 in a single day. Oak Street Health plans to continue after-hours clinics and will begin vaccinating high-risk patients as vaccine supply permits, with the goal of vaccinating 10,000 seniors weekly.
Oak Street Health (NYSE: OSH) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11. CEO Mike Pykosz is scheduled to present at 3:40 p.m. EST. Investors can access a live and archived webcast of the event on the company's website for 30 days post-event. Oak Street Health operates over 70 value-based primary care centers for Medicare adults across multiple states, prioritizing quality care and assuming financial risk for its patients.
Oak Street Health is offering free rapid COVID-19 testing to the Chicago community, collaborating with the City of Chicago. Over 2,500 tests have been administered without the need for appointments or insurance. The testing is available to everyone, regardless of symptom status. The initiative addresses the increased demand for testing, particularly in neighborhoods affected disproportionately by the virus. Testing is conducted every Monday through Saturday from 9:30 AM to 4 PM at various locations, with additional sites opening soon.
Oak Street Health (NYSE: OSH) has expanded its healthcare services in the Dallas-Fort Worth area by opening three new Community Clinics within Walmart supercenters, adding to an existing center in Mesquite, Texas. This expansion aims to improve access to affordable healthcare for adults on Medicare. The clinics will offer comprehensive primary care and urgent services with a focus on quality over quantity, reflecting the company's mission to transform healthcare delivery. Oak Street Health now operates eight centers in Texas and over 70 nationwide.
Oak Street Health (NYSE: OSH) is set to expand its operations, entering Louisiana and South Carolina in early 2021. New centers will be established in New Orleans, Columbia, and Greenville/Spartanburg, marking the company's twelfth and thirteenth states. Additionally, Oak Street Health will open new centers in Akron, Ohio, and Raleigh, North Carolina. The company has significantly reduced patient hospital admissions, readmission rates, and emergency department visits, while maintaining a high Net Promoter Score of 90.
Oak Street Health, Inc. (NYSE: OSH) has priced its public offering of 5,632,430 shares of common stock at $46.00 each, up from an earlier announcement of 5,284,603 shares. The offering will close on December 7, 2020. Notably, the company will not receive any proceeds from this share sale; all costs are borne by the selling stockholders. Additionally, underwriters have a 30-day option to purchase an extra 844,863 shares. Major underwriters include J.P. Morgan, Goldman Sachs, and Morgan Stanley.
